Disease Info Card

Acute Undifferentiated Leukemia

Information about Acute Undifferentiated Leukemia: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Acute Undifferentiated Leukemia

Most recent studies have shown that Acute Undifferentiated Leukemia shares some biological mechanisms with acute-leukemia, acute-lymphocytic-leukemia, blast-phase, cell-transformation-neoplastic, chromosomal-translocation, cytogenetic-abnormality, dysmyelopoietic-syndromes, hematologic-neoplasms, leukemia, leukemia-myelocytic-acute, lymphoid-leukemia, lymphoma, malignant-neoplasms, malignant-paraganglionic-neoplasm, myeloblastic-leukemia, myeloid-leukemia, myeloid-leukemia-chronic, neoplasms, precursor-b-cell-lymphoblastic-leukemia-lymphoma, precursor-t-cell-lymphoblastic-leukemia-lymphoma.

Among the many pathways, these few ones have gauged particular interests from scientists studying Acute Undifferentiated Leukemia, and have been seen in publications frequently: Angiogenesis, Cell Cycle, Cell Death, Cell Development, Cell Differentiation, Cell Fate Determination, Cell Growth, Cell Proliferation, Drug Resistance, Hemopoiesis, Induction Of Apoptosis, Localization, Oncogenesis, Pathogenesis, Phagocytosis, S Phase, Secretion, Stem Cell Development, Transport, Vasculogenesis

Quite a number of genes have been found to play important roles in Acute Undifferentiated Leukemia, such as ANPEP, BCR, CD33, CD34, CD7, CTLA4, DNTT, FANCB, FUT1, GATA1, HLA-DQA1, KIT, KRT7, MME, MPO, NOD2, SCLY, SET, TAL1. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.